NKE vs UPS: Which Is the Better Buy?

Side-by-side comparison of NIKE, Inc. and United Parcel Service, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
NIKE, Inc. Β· Consumer Cyclical
$42.62
+45.5% upside to fair value
Med Conviction Grade B+
VS
United Parcel Service, Inc. Β· Industrials
$101.69
+27.8% upside to fair value
Med Conviction Grade B-
QuantHub Verdict
NKE has more upside to fair value (+45.5%). UPS trades at a lower forward P/E (15.1x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NKE UPS
Current Price $42.62 $101.69
Fair Value Estimate $62.00 $130.00
Upside to Fair Value +45.5% +27.8%
Market Cap $63.0B $86.4B
Forward P/E 27.9x 15.1x
EV / EBITDA 20.7x 9.1x
Price / Sales 1.4x 0.9x
Price / FCF 19.4x 17.7x
Revenue Growth YoY -9.8% -2.5%
Gross Margin 42.7% 18.5%
Operating Margin 8.0% 9.56%
Return on Equity 24.4% 34.3%
Dividend Yield 3.8% 6.41%
FCF Yield 5.2% 5.66%
Analyst Consensus Buy Hold
Investment Thesis
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
UPS β€” United Parcel Service, Inc.
UPS is the world's largest integrated logistics network with 241,250 employees, operations in 200-plus countries, and 20.8 million packages per day, now in the decisive phase of its most consequential restructuring in 118 years. By deliberately cutting Amazon volume by more than 50 percent (Amazon was 10.6 percent of 2025 revenue), closing 22 to 24 facilities, and eliminating 30,000 positions, ma…
Accumulation Zones
Metric NKE UPS
Zone Low $44.00 $95.00
Zone High $50.00 $112.00
In Buy Zone? Yes Yes
← NKE Research    UPS Research β†’    All Research